<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02440217</url>
  </required_header>
  <id_info>
    <org_study_id>CardMet</org_study_id>
    <nct_id>NCT02440217</nct_id>
  </id_info>
  <brief_title>Myocardial Metabolism in Patients With Dilated Cardiomyopathy</brief_title>
  <official_title>Abnormal Glucose Tolerance is Associated With a Reduced Myocardial Metabolic Flexibility in Patients With Dilated Cardiomyopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero, Universitaria Pisana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero, Universitaria Pisana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dilated cardiomyopathy (DCM) is characterized by a metabolic shift from fat to carbohydrates
      and failure to increase myocardial glucose uptake in response to workload increments. The
      investigators aimed at verifying whether this pattern is influenced by the presence of
      abnormal glucose tolerance (AGT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A catheter is advanced into the coronary sinus by fluoroscopy to withdraw venous blood. A
      unipolar pacing catheter is positioned into the right atrium. Arterial sampling is done from
      the femoral artery introducer catheter.

      The study protocol consisted of 3 steps (Rest, Pacing and Recovery), during which timed blood
      samples are collected to measure plasma NEFA and glucose. After the instrumentation is
      completed, Rest arterio-venous sampling is performed at time -15 min and 0 min. After the 0
      min, heart rate is increased by atrial pacing to 110 bpm for 3 minutes and to 130 bpm for 3
      additional minutes and arterio-venous sampling is repeated at the end of each step (at time 3
      and 6 min). Pacing is then stopped and at time 1, 5, 15 and 30 min into the Recovery period
      other pairs of arterial and venous samples are withdrawn.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Myocardial metabolic responses to stress in humans</measure>
    <time_frame>Arterio-venous sampling will be performed in about an hour during three experimental condition: rest (time -15 and 0 min), pacing (3 and 6 min), and recovery (1, 5, 15 and 30 min).</time_frame>
    <description>The investigators aimed at evaluating myocardial NEFA and glucose uptake.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Dilated Cardiomyopathy</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>DCM-AGT</arm_group_label>
    <description>Subjects with both dilated cardiomyopathy (DCM) and abnormal glucose tolerance (AGT, either impaired glucose tolerance or type 2 diabetes).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DCM-NGT</arm_group_label>
    <description>Subjects with dilated cardiomyopathy (DCM) and normal glucose tolerance (NGT).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>N-AGT</arm_group_label>
    <description>Subjects without dilated cardiomyopathy (N) with abnormal glucose tolerance (AGT, either impaired glucose tolerance or type 2 diabetes).</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiology Department of the Institute of Clinical physiology
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        For patients with dilated cardiomyopathy:

          -  Myocardial left ventricular ejection fraction (LVEF) &lt;40%

          -  left ventricular end-diastolic diameter (LVEDD) &gt;56 mm

        For patients without dilated cardiomyopathy:

          -  LVEF &gt;50%

          -  LVEDD &lt;56 mm.

        Exclusion Criteria:

          -  NYHA class IV

          -  Atrial fibrillation

          -  Previous myocardial infarction

          -  Valvular heart disease

          -  Myocarditis

          -  Pericarditis

          -  Severe to moderate systemic arterial hypertension

          -  Fasting hyperglycaemia (&gt;7.0 mmol/l)

          -  Treated diabetes, autoimmune diseases, neoplasia, kidney, liver or respiratory failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Natali, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Azienda Ospedaliero, Universitaria Pisana</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria Pisana</name>
      <address>
        <city>Pisa</city>
        <state>PI</state>
        <zip>56127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005 Jul;85(3):1093-129. Review.</citation>
    <PMID>15987803</PMID>
  </reference>
  <reference>
    <citation>Neglia D, De Caterina A, Marraccini P, Natali A, Ciardetti M, Vecoli C, Gastaldelli A, Ciociaro D, Pellegrini P, Testa R, Menichetti L, L'Abbate A, Stanley WC, Recchia FA. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3270-8. Epub 2007 Oct 5.</citation>
    <PMID>17921325</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2015</study_first_submitted>
  <study_first_submitted_qc>May 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2015</study_first_posted>
  <last_update_submitted>May 7, 2015</last_update_submitted>
  <last_update_submitted_qc>May 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero, Universitaria Pisana</investigator_affiliation>
    <investigator_full_name>Andrea Natali</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

